Should supplier access be treated differently from internal user access under NIS2?

Why supplier access is not the same risk as internal user access

Supplier access is an external trust relationship, not a standard employee lifecycle. That matters because a third party may connect through different sponsorship, authentication, and approval paths, often with broader operational reach and less day-to-day visibility. Under NIS2, the control question is not just “who is allowed in,” but “how is external access constrained, reviewed, and justified over time?”

In practice, hospitals should treat supplier access as a separately governed access path with its own owner, scope, and expiry logic. A vendor connection that is acceptable for support or maintenance may still be inappropriate for routine standing access, shared accounts, or broad administrative reach. Third-Party, B2B and Contractor Access Guide is the clearest internal reference for that distinction.

That distinction also changes the evidence you should expect. Internal access can often be tied to joiner-mover-leaver processes, but supplier access should be tied to a documented business need, a named sponsor, and a review cadence that can prove the connection still exists and still needs the same level of privilege.

What NIS2 expects you to prove about external access

NIS2 pushes organisations toward proportionate, risk-based security controls rather than a single generic access model for everyone. For supplier access, the relevant test is whether the organisation can show authenticated access, least-privilege scope, and governance over persistence, especially where third parties can reach critical systems or sensitive operational environments. The directive’s supply-chain security language makes that distinction operationally important. EU NIS2 Directive is the primary legal reference for that obligation.

That is why external access usually needs stronger documentation than internal access. You should be able to show who approved the connection, what systems it can reach, whether the supplier is using named identities or shared credentials, and what review or offboarding step removes the access when the contract, incident, or maintenance window ends.

Identity governance matters here because supplier access is still access governance, just with a different trust boundary. IAM and IGA Basics is useful where you need to separate authentication, authorization, provisioning, and access review into distinct controls rather than treating all access as one process.

How to decide when supplier access needs extra restriction or review

The practical decision rule is simple: if the supplier can touch production, patient-facing, clinical, or operationally critical systems, treat the access as elevated risk even when it is legitimate. That means tighter approval, narrower scope, time limits, and more frequent recertification than a typical internal user path. Continuous access should be an exception, not the default, and it should require a stronger justification than convenience or historical practice.

Access reviews are the control that keeps this from drifting into permanent third-party standing access. A good review process should ask whether the supplier still needs the access, whether the level of privilege matches the current task, and whether the access can be replaced by a more constrained support model. Access Reviews and Certification Guide is relevant because supplier access often fails at the “reviewed but never removed” stage.

When the supplier is supporting cloud workloads or remote administration paths, the same discipline should extend to the technical authentication method. Cloud Workload Identity Guide helps when the supplier connection depends on service identities, temporary credentials, or federated access rather than human logins.

Risk and Threat Considerations

Supplier access creates a different threat surface because it can bypass the normal staff lifecycle and bring an outside dependency directly into critical environments. If the supplier’s credentials, support tooling, or remote channel are compromised, the exposure is not confined to one user account, it can become a pathway into multiple systems that the supplier was trusted to maintain.

Failure mechanism: The control fails when external access is granted broadly, left active after the need has passed, or managed through shared or long-lived credentials that are not reviewed at the same pace as internal accounts.

Impact: That can enable unauthorized access, harder attribution, lateral movement through supported systems, and a wider blast radius if the supplier relationship is abused or compromised.

Practitioner Guidance

What to prioritise: Separate supplier access from internal user access in policy, review, and technical enforcement. Give it an explicit owner, an expiry or review date, and a business justification that is recorded before access is granted.

What to verify: Confirm whether the supplier uses named identities, whether access is time-bound, and whether you can revoke it quickly without relying on the supplier to self-report the end of need. If you cannot demonstrate those three points, the access is too close to standing privilege.

Common mistake: Treating a trusted vendor as if trust were a substitute for control. The stronger the operational dependency, the more important it is to keep access narrow, attributable, and easy to remove.

Practitioner takeaway: The right question is not whether suppliers should ever have access, but whether every supplier connection has a tighter control story than an internal employee account would need.

Related resources from NHI Mgmt Group

• Should third-party access be governed differently from internal user access in GRC workflows?
• Should organisations treat partner OAuth grants differently from internal user access?
• How should security teams run access reviews for non-human identities?
• How should security teams govern non-human identities that have persistent access?